HALO - Halozyme Therapeutics Inc. (HALO) CEO Dr. Helen Torley on Q4 2018 Results - Earnings Call Transcript
Halozyme Therapeutics, Inc. (HALO)
Q4 2018 Earnings Conference Call
February 21, 2019 04:30 PM ET
Company Participants
Al Kildani - VP of IR and Corporate Communications
Dr. Helen Torley - President, CEO & Director
Laurie Stelzer - SVP & CFO
Conference Call Participants
Jim Birchenough - Wells Fargo Securities
Charles Duncan - Cantor Fitzgerald
Arlinda Lee - Canaccord
Presentation
Operator
Good afternoon everyone. We now have Halozyme Conference. Please be aware that each of your line is a listen-only mode. At the conclusion of today’s presentation, we will open the floor for question. At that